137 related articles for article (PubMed ID: 24840114)
1. Evaluation of Cardiac Markers in Children Undergoing Hematopoietic Stem Cell Transplantation.
Ozturk G; Tavil B; Ozguner M; Ginis Z; Erden G; Tunc B; Azik MF; Uckan D; Delibas N
J Clin Lab Anal; 2015 Jul; 29(4):259-62. PubMed ID: 24840114
[TBL] [Abstract][Full Text] [Related]
2. The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia.
Horacek JM; Vasatova M; Tichy M; Pudil R; Jebavy L; Maly J
Exp Oncol; 2010 Jul; 32(2):97-9. PubMed ID: 20693970
[TBL] [Abstract][Full Text] [Related]
3. Influence of acute physical exercise on emerging muscular biomarkers.
Lippi G; Schena F; Montagnana M; Salvagno GL; Guidi GC
Clin Chem Lab Med; 2008; 46(9):1313-8. PubMed ID: 18636795
[TBL] [Abstract][Full Text] [Related]
4. Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia.
Horacek JM; Tichy M; Jebavy L; Pudil R; Ulrychova M; Maly J
Exp Oncol; 2008 Jun; 30(2):157-9. PubMed ID: 18566582
[TBL] [Abstract][Full Text] [Related]
5. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.
Okamoto F; Sohmiya K; Ohkaru Y; Kawamura K; Asayama K; Kimura H; Nishimura S; Ishii H; Sunahara N; Tanaka T
Clin Chem Lab Med; 2000 Mar; 38(3):231-8. PubMed ID: 10905760
[TBL] [Abstract][Full Text] [Related]
6. A unique case series of novel biomarkers of cardiac damage in cyclists completing the 4800 km Race Across America (RAAM).
Williams K; George K; Hulton A; Godfrey R; Lahart I; Wilson MG; Charlesworth S; Warburton D; Gaze D; Whyte G
Curr Med Chem; 2011; 18(23):3446-51. PubMed ID: 21756241
[TBL] [Abstract][Full Text] [Related]
7. Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology.
Mion MM; Novello E; Altinier S; Rocco S; Zaninotto M; Plebani M
Clin Biochem; 2007 Nov; 40(16-17):1245-51. PubMed ID: 17894935
[TBL] [Abstract][Full Text] [Related]
8. Multimarker approach to evaluation of cardiac toxicity during preparative regimen and hematopoietic cell transplantation.
Horacek JM; Tichy M; Pudil R; Jebavy L; Zak P; Ulrychova M; Slovacek L; Maly J
Neoplasma; 2008; 55(6):532-7. PubMed ID: 18999883
[TBL] [Abstract][Full Text] [Related]
9. [Value of combined detection of biomarkers in early diagnosis and prognosis of patients with septic myocardial injury].
Li Z; Cui S; Geng L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):443-448. PubMed ID: 34053488
[TBL] [Abstract][Full Text] [Related]
10. Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE).
Collinson PO; Gaze DC; Thokala P; Goodacre S
Health Technol Assess; 2013; 17(15):v-vi, 1-122. PubMed ID: 23597479
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome.
Cubranic Z; Madzar Z; Matijevic S; Dvornik S; Fisic E; Tomulic V; Kunisek J; Laskarin G; Kardum I; Zaputovic L
Biochem Med (Zagreb); 2012; 22(2):225-36. PubMed ID: 22838188
[TBL] [Abstract][Full Text] [Related]
12. Use of the biochip microarray system in detection of myocardial injury caused by radiofrequency catheter ablation.
Pudil R; Parízek P; Tichý M; Haman L; Horáková L; Ulrychová M; Vojácek J; Palicka V
Clin Chem Lab Med; 2008; 46(12):1726-8. PubMed ID: 19055449
[TBL] [Abstract][Full Text] [Related]
13. Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis.
Ye XD; He Y; Wang S; Wong GT; Irwin MG; Xia Z
Acta Pharmacol Sin; 2018 Jul; 39(7):1155-1163. PubMed ID: 29770799
[TBL] [Abstract][Full Text] [Related]
14. A Study on the Role of Heart Type Fatty Acid Binding Protein in the Diagnosis of Acute Myocardial Infarction.
Kabekkodu SP; Mananje SR; Saya RP
J Clin Diagn Res; 2016 Jan; 10(1):OC07-10. PubMed ID: 26894106
[TBL] [Abstract][Full Text] [Related]
15. [Levels of serum heart-type fatty acid-binding protein and its clinical significance in children with Kawasaki disease].
Sun YP; Wang WD; Wang JJ; Wang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr; 10(2):136-8. PubMed ID: 18433529
[TBL] [Abstract][Full Text] [Related]
16. Glycogen Phosphorylase BB: A more Sensitive and Specific Marker than Other Cardiac Markers for Early Diagnosis of Acute Myocardial Infarction.
Singh N; Rathore V; Mahat RK; Rastogi P
Indian J Clin Biochem; 2018 Jul; 33(3):356-360. PubMed ID: 30072837
[TBL] [Abstract][Full Text] [Related]
17. Heart type fatty acid binding protein is more sensitive than troponin I and creatine kinase myocardial band at early stage in determining myocardial injury caused by percutaneous coronary intervention.
Ozdemir L; Elonu OH; Gocmen AY
Int Heart J; 2011; 52(3):143-5. PubMed ID: 21646735
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of heart-type fatty acid binding protein determined by the rapid qualitative chromatographic immunoassay method for the detection of minor myocardial damage in patients presenting with non-ST elevation acute coronary syndrome.
Çavuşoğlu Y; Gök B; Demirüstü C; Birdane A; Görenek B; Ata N
Anadolu Kardiyol Derg; 2012 Nov; 12(7):584-90. PubMed ID: 22804980
[TBL] [Abstract][Full Text] [Related]
19. Laboratory diagnosis of patients with acute chest pain.
Penttilä I; Penttilä K; Rantanen T
Clin Chem Lab Med; 2000 Mar; 38(3):187-97. PubMed ID: 10905753
[TBL] [Abstract][Full Text] [Related]
20. Heart-type fatty acid binding protein as an adjunct to cardiac troponin-I for the diagnosis of myocardial infarction.
Kim KS; Lee HJ; Kim K; Jo YH; Kim TY; Lee JH; Rhee JE; Suh GJ; Kim MR; Lee CC; Singer AJ
J Korean Med Sci; 2011 Jan; 26(1):47-52. PubMed ID: 21218029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
